Dr. Danial Qasim Butt, BDS, MPhil, PhD (Oral & Maxillofacial Pathology) is a researcher specializing in translational cancer diagnostics, molecular pathology, and computational biology. His research focuses on the development of DNA aptamers as novel molecular recognition probes for cancer biomarker detection. His PhD research integrated computational design with histopathological validation to engineer and evaluate in silico DNA aptamers for oral squamous cell carcinoma (OSCC), targeting interferon-stimulated genes, including IFI6 (G1P3) and RSAD2. His broader research interests include oral oncology, biomarker discovery, molecular docking, molecular dynamics simulations, tumor microenvironment, bioinformatics, and precision medicine. He has also contributed to studies involving EGFR, Ki-67, mutant p53, vimentin, and exosomal microRNAs. Dr. Butt has authored several peer-reviewed publications in internationally indexed journals and actively collaborates on multidisciplinary research focused on translating computational discoveries into clinically applicable diagnostic technologies. His long-term research vision is to advance aptamer-based diagnostics and biosensor platforms for early cancer detection, personalized medicine, and improved patient outcomes.